Castration Resistant Prostate Cancer Treatment Market Report

Global and Region Castration Resistant Prostate Cancer Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：226
  • REPORT CODE：GMM891513
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Castration Resistant Prostate Cancer Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Castration Resistant Prostate Cancer Treatmentmarket, defines the market attractiveness level of Castration Resistant Prostate Cancer Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Castration Resistant Prostate Cancer Treatment industry, describes the types of Castration Resistant Prostate Cancer Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Castration Resistant Prostate Cancer Treatment market and the development prospects and opportunities of Castration Resistant Prostate Cancer Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Castration Resistant Prostate Cancer Treatment market in Chapter 13.

    By Player:

    • Abbott Laboratories

    • Active Biotech

    • Northwest Biotherapeutics

    • Glaxosmithkline

    • Hologic

    • Millennium Pharmaceuticals

    • Bayer Healthcare Pharmaceuticals

    • Spectrum Pharmaceuticals

    • Diagnocure

    By Type:

    • Hormonal Therapy

    • Adding An Anti-Androgen

    • Stopping An Anti-Androgen

    • Estrogens

    • Chemotherapy

    • Radiation Therapy

    • Others

    By End-User:

    • Hospital

    • Ambulatory Surgical Centers

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Castration Resistant Prostate Cancer Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Castration Resistant Prostate Cancer Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Castration Resistant Prostate Cancer Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Castration Resistant Prostate Cancer Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Castration Resistant Prostate Cancer Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Castration Resistant Prostate Cancer Treatment Consumption (2017-2022)

    • 7.2 United States Castration Resistant Prostate Cancer Treatment Consumption (2017-2022)

    • 7.3 Europe Castration Resistant Prostate Cancer Treatment Consumption (2017-2022)

    • 7.4 China Castration Resistant Prostate Cancer Treatment Consumption (2017-2022)

    • 7.5 Japan Castration Resistant Prostate Cancer Treatment Consumption (2017-2022)

    • 7.6 India Castration Resistant Prostate Cancer Treatment Consumption (2017-2022)

    • 7.7 South Korea Castration Resistant Prostate Cancer Treatment Consumption (2017-2022)

    8 Region and Country-wise Castration Resistant Prostate Cancer Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Castration Resistant Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Castration Resistant Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Castration Resistant Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 8.4 China Castration Resistant Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Castration Resistant Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 8.6 India Castration Resistant Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Castration Resistant Prostate Cancer Treatment Consumption Forecast (2022-2028)

    9 Global Castration Resistant Prostate Cancer Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Castration Resistant Prostate Cancer Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Hormonal Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Adding An Anti-Androgen Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Stopping An Anti-Androgen Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Estrogens Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Radiation Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Castration Resistant Prostate Cancer Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    10 Global Castration Resistant Prostate Cancer Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Castration Resistant Prostate Cancer Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Adding An Anti-Androgen Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Stopping An Anti-Androgen Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Estrogens Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Castration Resistant Prostate Cancer Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    11 Global Castration Resistant Prostate Cancer Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Castration Resistant Prostate Cancer Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Castration Resistant Prostate Cancer Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Castration Resistant Prostate Cancer Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Castration Resistant Prostate Cancer Treatment Market Competitive Analysis

    • 14.1 Abbott Laboratories

      • 14.1.1 Abbott Laboratories Company Details

      • 14.1.2 Abbott Laboratories Castration Resistant Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Abbott Laboratories Castration Resistant Prostate Cancer Treatment Product and Service

    • 14.2 Active Biotech

      • 14.2.1 Active Biotech Company Details

      • 14.2.2 Active Biotech Castration Resistant Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Active Biotech Castration Resistant Prostate Cancer Treatment Product and Service

    • 14.3 Northwest Biotherapeutics

      • 14.3.1 Northwest Biotherapeutics Company Details

      • 14.3.2 Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Product and Service

    • 14.4 Glaxosmithkline

      • 14.4.1 Glaxosmithkline Company Details

      • 14.4.2 Glaxosmithkline Castration Resistant Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Glaxosmithkline Castration Resistant Prostate Cancer Treatment Product and Service

    • 14.5 Hologic

      • 14.5.1 Hologic Company Details

      • 14.5.2 Hologic Castration Resistant Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Hologic Castration Resistant Prostate Cancer Treatment Product and Service

    • 14.6 Millennium Pharmaceuticals

      • 14.6.1 Millennium Pharmaceuticals Company Details

      • 14.6.2 Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product and Service

    • 14.7 Bayer Healthcare Pharmaceuticals

      • 14.7.1 Bayer Healthcare Pharmaceuticals Company Details

      • 14.7.2 Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product and Service

    • 14.8 Spectrum Pharmaceuticals

      • 14.8.1 Spectrum Pharmaceuticals Company Details

      • 14.8.2 Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product and Service

    • 14.9 Diagnocure

      • 14.9.1 Diagnocure Company Details

      • 14.9.2 Diagnocure Castration Resistant Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Diagnocure Castration Resistant Prostate Cancer Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Castration Resistant Prostate Cancer Treatment

    • Figure Castration Resistant Prostate Cancer Treatment Picture

    • Table Global Castration Resistant Prostate Cancer Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Castration Resistant Prostate Cancer Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Castration Resistant Prostate Cancer Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Castration Resistant Prostate Cancer Treatment Consumption by Country (2017-2022)

    • Figure United States Castration Resistant Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Castration Resistant Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Castration Resistant Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Castration Resistant Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Castration Resistant Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Castration Resistant Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Castration Resistant Prostate Cancer Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Castration Resistant Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Castration Resistant Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Castration Resistant Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Castration Resistant Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Castration Resistant Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Castration Resistant Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormonal Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Adding An Anti-Androgen Consumption and Growth Rate (2017-2022)

    • Figure Global Stopping An Anti-Androgen Consumption and Growth Rate (2017-2022)

    • Figure Global Estrogens Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Radiation Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adding An Anti-Androgen Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Stopping An Anti-Androgen Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Estrogens Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Castration Resistant Prostate Cancer Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Castration Resistant Prostate Cancer Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Castration Resistant Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Castration Resistant Prostate Cancer Treatment Product and Service

    • Table Active Biotech (Foundation Year, Company Profile and etc.)

    • Table Active Biotech Castration Resistant Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Active Biotech Castration Resistant Prostate Cancer Treatment Product and Service

    • Table Northwest Biotherapeutics (Foundation Year, Company Profile and etc.)

    • Table Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Product and Service

    • Table Glaxosmithkline (Foundation Year, Company Profile and etc.)

    • Table Glaxosmithkline Castration Resistant Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Glaxosmithkline Castration Resistant Prostate Cancer Treatment Product and Service

    • Table Hologic (Foundation Year, Company Profile and etc.)

    • Table Hologic Castration Resistant Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hologic Castration Resistant Prostate Cancer Treatment Product and Service

    • Table Millennium Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product and Service

    • Table Bayer Healthcare Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product and Service

    • Table Spectrum Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product and Service

    • Table Diagnocure (Foundation Year, Company Profile and etc.)

    • Table Diagnocure Castration Resistant Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Diagnocure Castration Resistant Prostate Cancer Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US